2005
| Dec.12,2005 | Agreement on Joint Development and Marketing of Rivastigmine Transdermal Patch for the Treatment of Alzheimer's Disease (95.5KB) |
| Nov.04,2005 | Ono Entered Into Drug Discovery Agreement on Kinases with Array BioPharma Inc. (63.2KB) |
| Oct.25,2005 | Patient Enrollment for Phase III Clinical Studies with New HIV Drug (ONO-4128 / 873140) Terminated (101KB) |
| Sep.20,2005 | Changes to the Development Program for ONO-4128 / 873140 (48.8KB) |
| Aug.10,2005 | Development status of ONO-2506PO/Cereact® Capsules (69.6KB) |
| Jul.25,2005 | Development Status Update of ONO-4128/873140 (7.9KB) |
| Jun.13,2005 | Results of Phase II Studies of Sitagliptin (MK-0431 / ONO-5345) Investigational Treatment for Type 2 Diabetes Presented by Merck & Co., Inc. at ADA (33.4KB) |
| May.26,2005 | Development Status of ONO-2506 for Injection/PROGLIA (9.3KB) |
| May.18,2005 | Announcement concerning Changes of Representative Directors (49.9KB) |
| May.12,2005 | Ono and Medarex Enter Into Collaborative Research Agreement on Antibody Product (53.2KB) |
| Apr.28,2005 | Ono resolved increase in dividends projected for the fiscal year 2004(ending on March 31,2005) (146KB) |
| Apr.28,2005 | Ono Pharmaceutical Announces Dissolution of a Subsidiary (16.9KB) |
| Mar.01,2005 | New Data on New HIV Drug(Oral CCR5 Receptor Antagonist) (21.8KB) |
| Feb.28,2005 | Development Status of ONO-2506 for Injection/PROGLIA outside Japan and Development Plan of Compounds in-licensed from Merck in Japan (97.5KB) |
| Jan.11,2005 | Opening of a Contributed Chair at Kyoto University, Graduate School of Medicine and Faculty of Medicine (8.7KB) |